Abstract:Our preliminary investigation has identified the potential of serum fucosylated extracellular vesicles (EVs) miR-4732-5p in the early diagnosis of lung adenocarcinoma (LUAD) by a fucose-captured strategy utilizing lentil lectin (LCA)-magnetic beads and subsequent screening of high throughput sequencing and validation of real-time quantitative polymerase chain reaction (RT-qPCR). Considering the relatively complicated procedure, expensive equipment, and stringent laboratory condition, we have constructed an electrochemical biosensor assay for the detection of miR-4732-5p. miR-4732-5p is extremely low in serum, down to the fM level, so it needs to be detected by highly sensitive electrochemical methods based on the Mg 2+ -dependent DNAzyme splitting nucleic acid lock (NAL) cycle and hybridization chain reaction (HCR) signal amplification. In this study, signal amplification is achieved through the dual amplification reactions using NAL cycle in combination with HCR. In addition, hybridized DNA strands bind to a large number of methylene blue (MB) molecules to enhance signaling. Based on the above strategy, we further enhance our signal amplification strategies to improve detection sensitivity and accuracy. The implementation of this assay proceeded as follows: initially, miR-4732-5p was combined with NAL, and then Mg 2+ -dependent DNAzyme splitted NAL to release auxiliary DNA (S1) strands, which were subsequently captured by the immobilized capture probe DNA (C1) strands on the electrode surface. Following this, abundant quantities of DNA1 (H1) and DNA2 (H2) tandems were generated by HCR, and S1 strands then hybridized with the H1 and H2 tandems through base complementary pairing. Finally, MB was bonded to the H1 and H2 tandems through π–π stacking interaction, leading to the generation of a signal current upon the detection of a potential capable of inducing a redox change of MB by the electrode. Furthermore, we evaluated the performance of our developed electrochemical biosensor assay. The results demonstrated that our assay is a reliable approach, characterized by its high sensitivity (with a detection limit of 2.6 × 10 −17 M), excellent specificity, good accuracy, reproducibility, and stability. Additionally, it is cost-effective, requires simple operation, and is portable, making it suitable for the detection of serum fucosylated extracellular vesicles miR-4732-5p. Ultimately, this development has the potential to enhance the diagnostic efficiency for patients with early-stage LUAD.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the diagnostic efficiency of early - stage lung adenocarcinoma (LUAD). Specifically, the researchers have developed a new method based on an electrochemical biosensor for detecting microRNA - 4732 - 5p (miR - 4732 - 5p) in glycosylated extracellular vesicles (EVs) in serum. This method aims to overcome the limitations of existing detection methods (such as RT - qPCR), such as expensive equipment, complex operation, and strict laboratory conditions, and provide a cost - effective, simple - to - operate, and portable detection means. ### Main research background and objectives 1. **Lung cancer and the importance of its early diagnosis**: - Lung cancer is one of the most common and deadly malignant tumors, posing a serious threat to human health. - Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer, accounting for approximately 40% of all cases. - Due to its highly invasive and rapid metastasis characteristics, early diagnosis is crucial for improving the prognosis of LUAD patients. 2. **Limitations of existing diagnostic methods**: - Low - dose spiral CT has difficulty effectively distinguishing benign lung nodules smaller than 1 cm when screening early - stage LUAD patients, leading to problems of false positives and over - diagnosis. - The cargo in extracellular vesicles (EVs), especially miRNA, has been proven to have diagnostic potential, but efficient isolation of cancer - cell - derived EVs remains a challenge. 3. **Researchers' preliminary findings**: - Through the use of the locust bean lectin (LCA) magnetic bead capture strategy, combined with high - throughput sequencing and real - time quantitative PCR (RT - qPCR) verification, the researchers found that glycosylated extracellular vesicle miR - 4732 - 5p in serum may be a potential serological marker for early - stage LUAD. 4. **Purpose of developing an electrochemical biosensor**: - In order to overcome the limitations of existing methods such as RT - qPCR, the researchers have developed a new - type biosensor based on an electrochemical platform. - This biosensor utilizes Mg2+ - dependent DNAzyme - cleaved nucleic acid lock (NAL) cycling and hybridization chain reaction (HCR) signal amplification techniques to achieve high - sensitivity detection of miR - 4732 - 5p. ### Research methods and technical details 1. **Sample collection and processing**: - Blood samples from 36 hospitalized patients were collected from Fujian Provincial Hospital, including 18 early - stage LUAD patients and 18 benign pulmonary nodule (BPN) patients. - The blood samples were centrifuged to separate the serum and stored at - 80°C for later use. 2. **Isolation of extracellular vesicles and EVs - derived RNA**: - Glycosylated extracellular vesicles were isolated using an automatic instrument and the LCA magnetic bead method. - The characteristics of the isolated EVs were verified by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western Blotting. 3. **Construction and detection of the electrochemical biosensor**: - A gold electrode (GE) was prepared, and the capture probe (C1) and mercaptohexanol (MCH) were modified on its surface to reduce non - specific adsorption. - Different concentrations of miR - 4732 - 5p were mixed with NAL and Mg2+ solutions, incubated, and then dropped onto the modified electrode. - A large number of H1 and H2 tandem structures were generated through HCR and paired with the S1 strand through base - complementary pairing. - Finally, methylene blue (MB) molecules were added and bound to the H1 and H2 tandem structures through π - π stacking, generating an electric current signal. ### Experimental results 1. **Feasibility verification**: - The results of differential pulse voltammetry (DPV) showed that the current intensity increased significantly only when both DNAzyme and HCR were used simultaneously, proving the feasibility of this method. 2. **Linear range and sensitivity**: - The linear range of this biosensor is from 1 fM to 10^4 fM, and the detection limit is 2.6 × 10^-17 M, indicating its high sensitivity. 3. **Specificity**: - This biosensor has a relatively high specificity for the detection of miR - 4732 - 5p, and has a low response to mismatched miRNA and other miRNA. 4. **Accuracy**: - The recovery rate experiment showed that the average recovery rate of this biosensor is 97.72%, which meets the standard requirements.

Detection of fucosylated extracellular vesicles miR-4732-5p related to diagnosis of early lung adenocarcinoma by the electrochemical biosensor

Localized DNA tetrahedrons assisted catalytic hairpin assembly for the rapid and sensitive profiling of small extracellular vesicle-associated microRNAs

An ultrasensitive electrochemical/colorimetric dual-mode self-powered biosensing platform for lung cancer marker detection by multiple-signal amplification strategy

Programmable DNA-Fueled Electrochemical Analysis of Lung Cancer Exosomes

A sensitive and rapid electrochemical biosensor for sEV-miRNA detection based on domino-type localized catalytic hairpin assembly

Emerging electrochemical biosensors for lung cancer-associated protein biomarker and miRNA detection

A Versatile Electrochemical Biosensor for the Detection of Circulating MicroRNA toward Non‐Small Cell Lung Cancer Diagnosis (Small 22/2022)

Electrochemical detection of non-small cell lung cancer (NSCLC) mir-223 biomarker employing gold/MWCNT nanocomposite–based sandwich platform

Absolute Quantification and Analysis of Extracellular Vesicle Lncrnas from the Peripheral Blood of Patients with Lung Cancer Based on Multi-Colour Fluorescence Chip-Based Digital PCR.

Pump-free microfluidic chip based laryngeal squamous cell carcinoma-related microRNAs detection through the combination of surface-enhanced Raman scattering techniques and catalytic hairpin assembly amplification

DNAzyme-RCA-based colorimetric and lateral flow dipstick assays for the point-of-care testing of exosomal m5C-miRNA-21

Ultrasensitive electrochemical detection of miRNA based on polymerization signal amplification

All-in-one nanoflare biosensor combined with catalyzed hairpin assembly amplification for in situ and sensitive exosomal miRNA detection and cancer classification

Manufacturing of an electrochemical biosensing platform based on hybrid DNA hydrogel: Taking lung cancer-specific miR-21 as an example.

Rapid and Efficient Isolation and Detection of Extracellular Vesicles from Plasma for Lung Cancer Diagnosis.

Electrochemical Detection of Lung Cancer Specific Micrornas Using 3D DNA Origami Nanostructures.

Electrochemical micro-aptasensors for exosome detection based on hybridization chain reaction amplification

A Panel of Mirnas Derived from Plasma Extracellular Vesicles As Novel Diagnostic Biomarkers of Lung Adenocarcinoma

Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer

High Fidelity Detection of miRNAs from Complex Physiological Samples Through Electrochemical Nanosensors Empowered by Proximity Catalysis and Magnetic Separation

Sensitive and Specific Y-Shaped Ratio Biosensor for Detecting Serum miR-18a: Potential Early Scanning Tool for Non-Small Cell Lung Cancer